Controlled-Release Dosage Forms for Diltiazem Hydrochloride

Panchagnula,Ramesh;

Controlled-Release Dosage Forms for Diltiazem Hydrochloride

April 2, 2004

By Ramesh Panchagnula, PhD

Publication

Article

Pharmaceutical TechnologyPharmaceutical Technology-04-02-2004

Volume 28

Issue 4

The authors investigate whether an extrusion-spheronization proces can be used to develop a matrix-based, controlled-release formulation for a highly water-soluble drug.

External Link - article-91088.pdf

Articles in this issue

Spotlight on Business Risk

Vibration Technology for Active Dry-Powder Inhalers

In the Spotlight April 2004

FDA Attacks Counterfeits

Synthetic Excipients Challenge All-Natural Organics

April 2004

Controlled-Release Dosage Forms for Diltiazem Hydrochloride

Related Content

Movement towards the intended goal. Moving forward, step by step. Labor and aspiration. Motivation, self-development. Business strategic planning, risk management. New opportunities. Achieve. | Image Credit: ©Andrii Yalanskyi – Stock.Adobe.com

Steps to Process Development Optimization

Susan Haigney

February 4th 2025

Article

The optimization of processes for the development and manufacture of biopharmaceuticals is pivotal for producing quality products.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol

April 30th 2024

Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

3d rendering of Antibody drug conjugates (ADCs) are targeted medicines that deliver chemotherapy agents to cancer cells | Image Credit: © Love Employee - © Love Employee- stock.adobe.com

Advancing ADCs to the Next Level

Feliza Mirasol

February 4th 2025

Article

CDMOs who have integrated technologies can help further the advancement of ADC development.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024

Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.